Pipeline.
Pipeline.
Improving Patient Outcomes.
A pipeline of synergistic, highly differentiated diagnostic and drug candidates leverage our novel cellular metabolism approach.
Targeted Therapeutics & Validated Diagnostics Driven by Female Biology Data
Post operative Tissue Fibrosis
TTX333
A single-dose therapy that inhibits fibrotic tissue growth at the surgical site.
Learn more
ENDOMETRIOSIS
TTX334Dx, TTX334e
A clinically validated non-invasive diagnostic platform and novel disease modifying non-hormonal targets.
Learn more
Gyne Oncology
TTX335o, TTX335oDx
A novel biomarker for early detection coupled with a novel target and molecule for ovarian cancer.
Learn more
Polycystic Ovarian Syndrome (PCOS)
TTX336
A novel targeted best-in-class therapeutic with disease-modifying potential.
Learn more
Post operative Tissue Fibrosis
TTX333
A single-dose therapy that inhibits fibrotic tissue growth at the surgical site.
ENDOMETRIOSIS
TTX334Dx, TTX334e
A clinically validated non-invasive diagnostic platform and novel disease modifying non-hormonal targets.
Gyne Oncology
TTX335o, TTX335oDx
A novel biomarker for early detection coupled with a novel target and molecule for ovarian cancer.
Polycystic Ovarian Syndrome (PCOS)
TTX336
A novel targeted best-in-class therapeutic with disease-modifying potential.